International Randomized Comparison Between DES Limus Carbostent and Taxus Drug Eluting Stents in the Treatment of De-novo Coronary Lesions (NEXT)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by:

CID - Carbostent & Implantable Devices

ClinicalTrials.gov Identifier:

NCT01373502

First received: September 24, 2010

Last updated: February 20, 2012

Last verified: February 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2015
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)

No publications provided by CID - Carbostent & Implantable Devices

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Carrié D, Berland J, Verheye S, Hauptmann KE, Vrolix M, Violini R, Dibie A, Berti S, Maupas E, Antoniucci D, Schofer J. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions. J Am Coll Cardiol. 2012 Apr 10;59(15):1371-6. Epub 2012 Jan 25.

To Top